abstract |
Extracellular vesicle (EV) compositions, specifically exosomes and microvesicles are disclosed together with the use of such EV compositions, exosomes and microvesicles, in treatment of skin disorders, and lung conditions such as COVID-19, over-reactive inflammatory responses, cytokine storms and/or ARDS. |